NDC 33342-447

Pyrazinamide

Pyrazinamide

Pyrazinamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is Pyrazinamide.

Product ID33342-447_3695f057-de86-4c9a-9d43-ff0a6acdffe7
NDC33342-447
Product TypeHuman Prescription Drug
Proprietary NamePyrazinamide
Generic NamePyrazinamide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-07-27
Marketing CategoryANDA / ANDA
Application NumberANDA212541
Labeler NameMacleods Pharmaceuticals Limited
Substance NamePYRAZINAMIDE
Active Ingredient Strength500 mg/1
Pharm ClassesAntimycobacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 33342-447-03

10 TABLET in 1 BOTTLE (33342-447-03)
Marketing Start Date2020-07-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pyrazinamide" or generic name "Pyrazinamide"

NDCBrand NameGeneric Name
0904-6696PyrazinamidePyrazinamide
10135-735PYRAZINAMIDEpyrazinamide tablet
33342-447PyrazinamidePyrazinamide
50090-0520PyrazinamidePyrazinamide
50090-0521PyrazinamidePyrazinamide
50090-5963PyrazinamidePyrazinamide
55695-026PyrazinamidePyrazinamide
60687-138PyrazinamidePyrazinamide
61748-012PyrazinamidePyrazinamide
67253-660PyrazinamidePyrazinamide
70518-0085PyrazinamidePyrazinamide
70518-2534PyrazinamidePyrazinamide
70954-484PyrazinamidePyrazinamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.